Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service

DG Lamprecht Jr, PB Shaw, JB King, KN Hogan… - Journal of Clinical …, 2018 - Elsevier
Background Although high-intensity statin therapy (HIST) is recommended for most patients
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …
被引用次数：8 相关文章

Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service

DG Lamprecht, PB Shaw, JB King, KN Hogan… - 2018 - epublications.regis.edu
Background: Although high-intensity statin therapy (HIST) is recommended for most patients
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …

Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service

DG Lamprecht, PB Shaw, JB King… - Journal of Clinical …, 2018 - lipidjournal.com
Background Although high-intensity statin therapy (HIST) is recommended for most patients
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …

Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service

DG Lamprecht Jr, PB Shaw, JB King… - Journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Although high-intensity statin therapy (HIST) is recommended for most patients
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …

Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service.

DG Lamprecht Jr, PB Shaw, JB King… - Journal of Clinical …, 2018 - europepmc.org
Background Although high-intensity statin therapy (HIST) is recommended for most patients
between 21 and 75 years of age with atherosclerotic cardiovascular disease (ASCVD) …